Table 4.
Secondary outcomes.
Received capsaicin (n = 149) | Did not receive capsaicin (n = 52) | p | OR | 95% CI | β | |
---|---|---|---|---|---|---|
Secondary outcomes | ||||||
| ||||||
Total ED length of stay (median) – hours | 6.1 | 5.25 | 0.372 | |||
Total medications for symptom relief received – median, No. (range) | 4 (0–60) | 4 (0–43) | 0.934 | |||
Admitted due to uncontrolled CHS symptoms – No. (%) | 39 (26.2) | 13 (25) | 0.868 | 1.01 | 0.8190–1.183 | |
Return to ED in 24 h for same symptoms or complaint – No. (%) | 8 (5.4) | 3 (5.8) | 0.913 | 1.02 | 0.704–1.479 | |
Time to discharge or admission after administration of capsaicin or first agent (average) – hours | 3.72 | 6.11 | 0.001 | 2.799–3.501 | ||
Change in pain score after administration of capsaicin or first agent – average (126 complete records) | +0.94 | +1.38 | 0.464 | −1.636 - 0.750 | −0.443 | |
Change in episodes of emesis after administration of capsaicin or first agent (14 complete records) | +0.03 | −0.21 | 0.423 | −3.575–1.624 | −0.975 |